Alkem Laboratories Ltd

Alkem Lab Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Alkem Laboratories Ltd

₹ 4,848 -0.79%
12 Jun 3:05 p.m.
alkemlabs.com BSE: 539523 NSE: ALKEM
About

Alkem Laboratories is engaged in pharmaceutical business with global operations. The Company is engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products.(Source : 202003-01 Annual Report Page No:107)

Key Points

Leading Pharmaceutical company[1]
Alkem Laboratories holds a 4.1% market share in the Indian domestic formulation market as of 9M FY25, making it the 5th largest pharmaceutical company in India. The company maintains its #1 position in anti-infectives and has a strong presence in gastrointestinal, pain management, vitamins, minerals, and nutrients segments while also expanding in chronic therapies like neurology, cardiology, and diabetology.

Website BSE NSE
  • Market Cap ₹ 57,965 Cr.
  • Current Price ₹ 4,848
  • High / Low ₹ 6,440 / 4,492
  • Stock P/E 27.7
  • Book Value ₹ 1,031
  • Dividend Yield 0.82 %
  • ROCE 19.5 %
  • ROE 18.3 %
  • Face Value ₹ 2.00
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Company has been maintaining a healthy dividend payout of 34.6%

Cons

  • Promoter holding has decreased over last quarter: -0.53%
  • The company has delivered a poor sales growth of 5.71% over past five years.
  • Tax rate seems low
  • Earnings include an other income of Rs.698 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Part of BSE 500 BSE Healthcare BSE 200 Nifty 500 BSE MidCap

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
2,006 2,058 2,461 2,297 2,238 2,253 2,635 2,009 2,365 2,500 2,355 2,287 2,045
1,807 1,875 2,056 1,841 1,906 1,919 1,980 1,517 1,958 1,879 1,714 1,629 1,748
Operating Profit 200 183 406 456 332 334 655 492 408 621 640 658 297
OPM % 10% 9% 16% 20% 15% 15% 25% 25% 17% 25% 27% 29% 15%
54 55 74 61 77 65 62 93 71 106 176 216 163
Interest 13 22 20 23 22 21 19 21 21 21 17 21 17
Depreciation 55 57 58 58 57 58 59 57 69 64 61 68 92
Profit before tax 186 160 402 436 330 319 639 508 389 641 738 785 351
Tax % 59% 12% 13% 11% 23% 15% -1% 1% 16% 9% 5% 8% 21%
77 140 351 389 255 271 647 504 325 583 698 723 277
EPS in Rs 6.43 11.72 29.33 32.53 21.31 22.70 54.07 42.17 27.18 48.78 58.34 60.48 23.16
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
2,660 3,072 3,911 4,548 5,281 5,714 6,677 7,220 8,830 9,055 9,748 8,813
2,261 2,722 3,180 3,668 4,308 4,667 5,209 5,268 7,018 7,665 7,780 6,657
Operating Profit 399 350 731 880 973 1,048 1,468 1,951 1,812 1,389 1,968 2,156
OPM % 15% 11% 19% 19% 18% 18% 22% 27% 21% 15% 20% 24%
164 177 240 115 101 66 96 175 199 254 239 698
Interest 84 73 59 24 32 28 39 43 38 86 82 76
Depreciation 43 60 74 76 108 141 187 199 219 230 244 284
Profit before tax 436 395 839 894 934 944 1,338 1,884 1,753 1,327 1,881 2,495
Tax % -1% 7% 17% 1% 23% 15% 6% 11% 12% 15% 7% 9%
440 368 700 883 716 800 1,264 1,685 1,541 1,134 1,747 2,281
EPS in Rs 368.17 30.75 58.56 73.86 59.87 66.90 105.75 140.93 128.90 94.88 146.13 190.77
Dividend Payout % 5% 13% 22% 20% 22% 24% 24% 21% 26% 53% 27% 24%
Compounded Sales Growth
10 Years: 11%
5 Years: 6%
3 Years: 0%
TTM: -10%
Compounded Profit Growth
10 Years: 20%
5 Years: 11%
3 Years: 11%
TTM: 16%
Stock Price CAGR
10 Years: %
5 Years: 16%
3 Years: 16%
1 Year: -4%
Return on Equity
10 Years: 18%
5 Years: 18%
3 Years: 17%
Last Year: 18%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 12 24 24 24 24 24 24 24 24 24 24 24
Reserves 2,703 3,077 3,576 4,369 4,861 5,441 6,257 7,602 8,720 9,326 10,531 12,298
947 1,103 380 368 548 503 1,209 1,384 2,294 1,182 1,005 481
540 657 843 1,137 1,381 1,324 1,616 1,763 2,132 2,200 2,478 2,793
Total Liabilities 4,202 4,861 4,822 5,898 6,814 7,292 9,106 10,773 13,169 12,731 14,038 15,596
909 870 875 1,126 1,471 1,606 1,837 1,758 1,882 1,825 1,782 1,622
CWIP 0 96 147 218 299 382 314 323 232 229 91 46
Investments 940 1,071 1,158 1,518 1,544 1,696 1,956 2,152 2,529 3,006 2,829 4,407
2,352 2,824 2,644 3,037 3,500 3,609 4,999 6,539 8,526 7,672 9,336 9,521
Total Assets 4,202 4,861 4,822 5,898 6,814 7,292 9,106 10,773 13,169 12,731 14,038 15,596

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
264 242 630 499 318 745 682 1,324 1,299 1,437 1,687 2,189
119 -260 311 -362 -273 -313 -995 -1,121 -1,669 197 -866 -1,007
-395 26 -958 -125 -60 -276 173 -209 437 -1,711 -959 -1,037
Net Cash Flow -12 8 -17 13 -15 156 -141 -5 67 -77 -138 145

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 40 45 45 51 60 62 85 79 73 71 66 65
Inventory Days 161 143 139 175 180 159 156 207 202 164 177 196
Days Payable 88 90 110 139 144 121 116 131 114 103 151 188
Cash Conversion Cycle 113 97 74 86 97 100 125 155 162 133 92 72
Working Capital Days 68 63 45 59 81 82 105 113 106 96 176 200
ROCE % 15% 11% 22% 21% 19% 17% 20% 23% 18% 13% 18% 20%

Shareholding Pattern

Numbers in percentages

2 Recently
Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
57.14% 57.16% 57.16% 57.16% 57.16% 56.74% 56.74% 56.74% 56.38% 55.66% 55.66% 55.13%
5.67% 4.46% 4.41% 4.44% 5.63% 6.03% 8.49% 9.11% 8.69% 9.02% 10.14% 9.40%
14.10% 15.73% 16.44% 16.69% 16.34% 17.63% 15.91% 15.63% 18.56% 19.21% 18.01% 19.42%
23.09% 22.65% 21.99% 21.69% 20.85% 19.58% 18.86% 18.51% 16.37% 16.12% 16.19% 16.05%
No. of Shareholders 84,10479,72176,51673,44066,79069,44265,18465,83069,62774,74484,03884,326

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls